This issue reminds us that humankind remains the enduring question, and diversity in clinical trials is the answer (even if machine learning hops on for the ride!). We've also got features reflecting healthcare and society: health comms meets stand-up comedy, the chaos of probiotics, and medicine governance in focus. Plus a report on the PharmaTimes Clinical Researcher of the Year Awards, and the GLP-1 tour rolls on.
























